Six-Minute Walk Test as a Predictive Measure of Exercise Capacity in Adults with Type 2 Diabetes

Area of Science:

• Cardiology
• Endocrinology
• Exercise Physiology

Background:

• The 6 Minute Walk Test (6MWT) is a standard measure for assessing treatment response in cardiopulmonary diseases.
• Its validity for measuring exercise capacity in type 2 diabetes (T2DM) patients has not been established.
• Type 2 diabetes is a highly prevalent condition affecting exercise capacity.

Purpose of the Study:

• To investigate the correlation between the 6MWT and graded exercise testing (GXT) in adults with T2DM.
• To validate the 6MWT as a tool for assessing exercise capacity in this population.
• To determine if the 6MWT can reliably estimate exercise capacity in T2DM patients.

Main Methods:

• Secondary data analysis from the Program ACTIVE II randomized controlled trial.
• Examined the correlation between 6MWT distance and predicted VO2 max (PVO2M) derived from GXT.
• Analysis conducted at baseline and post-intervention in a subsample of T2DM participants.

Main Results:

• A significant correlation was found between 6MWT distance and PVO2M at baseline (r=0.57) and post-intervention (r=0.66).
• 6MWT distance alone explained 45% of the variability in PVO2M at baseline.
• Combined with the SF-12 PCS, 6MWT explained 66% of the variance in PVO2M, with 6MWT contributing an additional 30% after adjustment.

Conclusions:

• The 6MWT is significantly correlated with predicted exercise capacity in adults with T2DM.
• The 6MWT is a valid and reliable tool for estimating exercise capacity in this patient group.
• This finding supports the use of 6MWT for assessing exercise capacity in T2DM management.